Financing
Financing Cash Flow
Revolution Medicines, Inc. Financing Cash Flow decreased by 34.7% to $238.74M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 27216.2%, from $874.00K to $238.74M. Over 4 years (FY 2021 to FY 2025), Financing Cash Flow shows an upward trend with a 20.6% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2018
Last reportedQ1 2026May 6, 2026
How to read this metric
Negative values often indicate a company is paying down debt or returning capital to shareholders, while positive values may indicate external financing.
Detailed definition
The net result of all cash inflows and outflows related to financing activities, including debt issuance, debt repayment...
Peer comparison
Highly dependent on the company's current capital structure and lifecycle stage compared to industry peers.
Metric ID:
net_cash_from_financingHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $868.00K | $319.00K | $10.73M | $305.00K | $1.43M | $248.34M | $51.36M | $324.21M | $64.63M | $1.01M | $839.35M | $810.00K | $7.50M | $77.29M | $873.81M | $874.00K | $256.58M | -$1.59M | $365.66M | $238.74M |
| QoQ Change | — | -63.2% | >999% | -97.2% | +368.5% | >999% | -79.3% | +531.2% | -80.1% | -98.4% | >999% | -99.9% | +826.4% | +930.0% | >999% | -99.9% | >999% | -100.6% | >999% | -34.7% |
| YoY Change | — | — | — | — | +64.6% | >999% | +378.8% | >999% | >999% | -99.6% | >999% | -99.8% | -88.4% | >999% | +4.1% | +7.9% | >999% | -102.1% | -58.2% | >999% |
Range-$1.59M – $873.81M
CAGR+226.3%
Avg YoY Growth>999%
Median YoY Growth+221.7%
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s financing cash flow?
- Revolution Medicines, Inc. (RVMD) reported financing cash flow of $238.74M in Q1 2026.
- How has Revolution Medicines, Inc.'s financing cash flow changed year-over-year?
- Revolution Medicines, Inc.'s financing cash flow increased by 27216.2% year-over-year, from $874.00K to $238.74M.
- What is the long-term trend for Revolution Medicines, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s financing cash flow has grown at a 20.6% compound annual growth rate (CAGR), from $294.18M to $621.52M.
- What does financing cash flow mean?
- The net cash flow generated or used by financing activities.